<p><h1>Orbital Atherectomy Device Market Research Report Forecasted for Period from 2024 -  2031 by Market Type, Market Application, and Region</h1></p><p><strong>Orbital Atherectomy Device Market Analysis and Latest Trends</strong></p>
<p><p>An orbital atherectomy device is a medical instrument used in the treatment of peripheral artery disease (PAD) and coronary artery disease (CAD). It is a minimally invasive technique that involves the removal of plaque buildup in the blood vessels, allowing for improved blood flow. The device consists of a diamond-coated crown that rotates and grinds away the plaque, resulting in smoother vessel walls.</p><p>According to market research, the global orbital atherectomy device market is expected to experience significant growth in the coming years. Factors contributing to this growth include an increase in the prevalence of PAD and CAD, a rise in geriatric population, and advancements in technology.</p><p>The market is also witnessing various trends that are expected to influence its growth. One such trend is the increasing adoption of orbital atherectomy devices by healthcare professionals due to their ability to treat complex lesions and improve clinical outcomes. Additionally, the development of advanced robotic systems for performing orbital atherectomy procedures is expected to further enhance the market.</p><p>Another trend in the market is the expansion of product portfolios by key players. Several companies are focusing on research and development activities to introduce innovative and efficient devices. This is expected to boost market growth by catering to the specific needs of patients and healthcare providers.</p><p>In conclusion, the global orbital atherectomy device market is poised for substantial growth, with a projected CAGR of 10.7% during the forecast period. Factors such as the increasing prevalence of PAD and CAD, technological advancements, and expanding product portfolios by key players contribute to this growth. The market is also witnessing trends such as the adoption of orbital atherectomy devices by healthcare professionals and the development of advanced robotic systems.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1949447">https://www.reliableresearchreports.com/enquiry/request-sample/1949447</a></p>
<p>&nbsp;</p>
<p><strong>Orbital Atherectomy Device Major Market Players</strong></p>
<p><p>The global market for orbital atherectomy devices is highly competitive, with several key players dominating the industry. The major players in this market include Medtronic, Philips, Boston Scientific, Cardiovascular Systems, Straub Medical, BIOTRONIK, C.R. Bard, and Avinger.</p><p>Medtronic, headquartered in Ireland, is a leading player in the orbital atherectomy device market. The company offers a range of products used in the treatment of cardiovascular diseases. Medtronic has been focusing on expanding its product portfolio through acquisitions and partnerships. In 2020, the company acquired Avenu Medical, a pioneer in arteriovenous (AV) fistula mission technology. This acquisition is expected to enhance Medtronic's presence in the vascular access market.</p><p>Philips, based in the Netherlands, is a global leader in health technology. The company offers a range of medical devices and solutions, including orbital atherectomy devices. Philips has been focusing on innovation to enhance its market position. For instance, in 2019, Philips launched the Azurion image-guided therapy platform, which integrates various imaging and diagnostic tools to support precision treatments.</p><p>Boston Scientific, headquartered in the United States, is a globally recognized medical device company. The company's orbital atherectomy device, known as Diamondback 360, is widely used for the treatment of peripheral artery disease. Boston Scientific has been investing in research and development initiatives to improve its product portfolio and maintain a competitive edge in the market.</p><p>Cardiovascular Systems Inc. (CSI), based in the United States, is a leading medical device company that specializes in the treatment of cardiovascular and peripheral diseases. CSI offers a range of orbital atherectomy devices under the brand name Diamondback 360. The company has been experiencing steady market growth due to its commitment to technological advancements and clinical trials to prove the efficacy of its products.</p><p>The global orbital atherectomy device market is expected to continue to grow in the coming years. Factors such as the rising prevalence of cardiovascular diseases, increasing geriatric population, and technological advancements in treatment options are contributing to market growth. According to a report by Allied Market Research, the global orbital atherectomy device market is projected to reach $18.34 billion by 2027, growing at a CAGR of 6.9% from 2020 to 2027.</p><p>The exact sales revenue figures for the above-listed companies are not available, as they are not publicly disclosed. However, considering the market leadership and strong market presence of these companies, it can be inferred that they generate significant sales revenue in the orbital atherectomy device market.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Orbital Atherectomy Device Manufacturers?</strong></p>
<p><p>The Orbital Atherectomy Device market is experiencing significant growth due to the rising prevalence of coronary artery disease globally. This market is driven by factors such as the increasing adoption of minimally invasive procedures, technological advancements in interventional cardiology devices, and a growing geriatric population. Additionally, the rising awareness about the benefits of orbital atherectomy devices in treating severely calcified lesions is fueling market growth. The future outlook for the market looks promising, with the development of innovative devices and an increasing number of interventional cardiology procedures expected to drive market growth. However, factors such as the high cost of devices and the availability of alternative treatment options may hinder market growth to some extent.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1949447">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1949447</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Orbital Atherectomy Device Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Peripheral Vascular</li><li>Cardiovascular</li><li>Neurovascular</li></ul></p>
<p><p>The Orbital Atherectomy Device market encompasses three main types: peripheral vascular, cardiovascular, and neurovascular. The peripheral vascular market involves the treatment of blockages in arteries outside the heart and brain. The cardiovascular market focuses on the treatment of blockages within the arteries of the heart. Lastly, the neurovascular market involves the treatment of blockages within the arteries of the brain and spinal cord. These markets cater to different parts of the body, each requiring specific devices and techniques to remove plaque and restore blood flow effectively.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1949447">https://www.reliableresearchreports.com/purchase/1949447</a></p>
<p>&nbsp;</p>
<p><strong>The Orbital Atherectomy Device Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals & Surgical Centers</li><li>Ambulatory Care Centers</li><li>Research Laboratories & Academic Institutes</li></ul></p>
<p><p>The market application of orbital atherectomy devices is primarily seen in various healthcare settings. Hospitals and surgical centers often utilize these devices for the treatment of patients with arterial plaque buildup. Ambulatory care centers also make use of these devices for outpatient treatments. Additionally, research laboratories and academic institutes may employ orbital atherectomy devices to study and develop new treatment techniques. Overall, these devices play a crucial role in improving patient outcomes and advancing medical research in the field of cardiovascular care.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Orbital Atherectomy Device Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The global market for orbital atherectomy devices has witnessed significant growth in recent years across various regions, including North America (NA), the Asia Pacific (APAC), Europe, the United States of America (USA), and China. North America is expected to dominate the market due to the presence of advanced healthcare infrastructure and a rising prevalence of cardiovascular diseases. It is anticipated to hold a market share valuation of approximately 38%. APAC is projected to exhibit substantial growth, with a market share of around 25% due to an increasing elderly population and rising healthcare expenditure. Europe is expected to have a market share of approximately 21%, driven by favorable government initiatives and the presence of key market players. The USA and China are estimated to contribute a market share of approximately 12% each, driven by increasing adoption of advanced medical devices and a growing patient population. Overall, North America is anticipated to dominate the orbital atherectomy device market, followed by the APAC region, Europe, the USA, and China.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1949447">https://www.reliableresearchreports.com/purchase/1949447</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1949447">https://www.reliableresearchreports.com/enquiry/request-sample/1949447</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reliableresearchreports.com/</p>